Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37
Closed -$571 4135
2022
Q4
$0 Sell
37
-452
-92% -$4.01K ﹤0.01% 4683
2022
Q3
$2K Sell
489
-260
-35% -$1.96K ﹤0.01% 4197
2022
Q2
$6K Sell
749
-3,285
-81% -$38.2K ﹤0.01% 3574
2022
Q1
$71K Buy
4,034
+3,840
+1,979% +$120K ﹤0.01% 1958
2021
Q4
$11K Sell
194
-945
-83% -$63.1K ﹤0.01% 3615
2021
Q3
$85K Buy
1,139
+891
+359% +$94.3K ﹤0.01% 2058
2021
Q2
$41K Sell
248
-938
-79% -$164K ﹤0.01% 2662
2021
Q1
$207K Buy
1,186
+678
+133% +$137K 0.01% 1250
2020
Q4
$104K Buy
508
+386
+316% +$71.7K ﹤0.01% 1498
2020
Q3
$23K Buy
+122
New +$29.4K ﹤0.01% 2348

Other funds holding GOCO

Cutler Group's GOCO Position: Q1 2023 in Review

Cutler Group sold out of GoHealth (GOCO) in Q1 2023, closing a stake of 37 shares — an estimated $571 sold.

Cutler Group first reported a position in GOCO in Q3 2020 and held it in 10 quarters. The position peaked at $207K in Q1 2021. 32 funds tracked by Wall St. Rank hold GOCO as of Q1 2023.

  • Cutler Group reported no remaining GoHealth position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 37 GoHealth shares in Q1 2023, an estimated $571.
  • Cutler Group first reported a position in GoHealth in Q3 2020 and held it in 10 quarters.
  • Cutler Group's GoHealth position peaked at $207K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held GoHealth as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.